Determination of hERG channel blockers using a decision tree
Authors:
- Michael C. HutterMHMichael C. Hutter
- 1 August 2006
- journal article
- Published by Elsevier in Bioorganic & Medicinal Chemistry
- Vol. 14 (15) , 5325-5332
Abstract
No abstract availableKeywords
This publication has 51 references indexed in Scilit:
- QT prolongation through hERG K+ channel blockade: Current knowledge and strategies for the early prediction during drug developmentMedicinal Research Reviews, 2004
- Structural Determinants of HERG Channel Block by Clofilium and IbutilideMolecular Pharmacology, 2004
- The impact of drug-induced QT interval prolongation on drug discovery and developmentNature Reviews Drug Discovery, 2003
- Understanding the Structure−Activity Relationship of the Human Ether-a-go-go-Related Gene Cardiac K+ Channel. A Model for Bad BehaviorJournal of Medicinal Chemistry, 2003
- Position of aromatic residues in the S6 domain, not inactivation, dictates cisapride sensitivity of HERG and eag potassium channelsProceedings of the National Academy of Sciences, 2002
- Molecular Determinants of Voltage-dependent Human Ether-a-Go-Go Related Gene (HERG) K+ Channel BlockJournal of Biological Chemistry, 2002
- HERG K+ channels: friend and foeTrends in Pharmacological Sciences, 2001
- A structural basis for drug-induced long QT syndromeProceedings of the National Academy of Sciences, 2000
- Spectrum of Mutations in Long-QT Syndrome GenesCirculation, 2000
- A mechanistic link between an inherited and an acquird cardiac arrthytmia: HERG encodes the IKr potassium channelCell, 1995